Auro Labs.

27
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE292C01011
  • NSEID:
  • BSEID: 530233
INR
239.00
-1 (-0.42%)
BSENSE

Jul 28, 02:07 PM

BSE+NSE Vol: 1.16 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 60.74% vs -64.34% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 219.80% vs -70.68% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 292.91% vs 47.13% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 92.14% vs -76.40% in Mar 2025

Compare Profit and Loss Results of Auro Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
30.00
103.00
-73.00
-70.87%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
30.00
103.00
-73.00
-70.87%
Expenditure (Ex Depriciation)
Stock Adjustments
-8.00
-4.00
-4.00
-100.00%
Raw Materials Consumed
14.00
83.00
-69.00
-83.13%
Power & Fuel Cost
1.00
0.00
1.00
0%
Employee Cost
5.00
4.00
1.00
25.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
0.00
2.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
20.00
87.00
-67.00
-77.01%
Operating Profit (PBDIT) excl Other Income
10.00
15.00
-5.00
-33.33%
Other Income
2.00
4.00
-2.00
-50.00%
Operating Profit (PBDIT)
12.00
20.00
-8.00
-40.00%
Interest
4.00
0.00
4.00
0%
Profit before Depriciation and Tax
7.00
19.00
-12.00
-63.16%
Depreciation
2.00
0.00
2.00
0%
Profit Before Taxation & Exceptional Items
4.00
18.00
-14.00
-77.78%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
18.00
-14.00
-77.78%
Provision for Tax
1.00
5.00
-4.00
-80.00%
Profit After Tax
3.00
13.00
-10.00
-76.92%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
35.00
14.00
21.00
150.00%
Profit Available for appropriations
39.00
27.00
12.00
44.44%
Appropriations
39.00
27.00
12.00
44.44%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.67
8.28
-2.61
-31.52%
Profit And Loss - Net Sales
Net Sales 30.74 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 60.74% vs -64.34% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 219.80% vs -70.68% in Mar 2025

Profit And Loss - Interest
Interest 4.25 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 292.91% vs 47.13% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 3.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 92.14% vs -76.40% in Mar 2025